Sabby Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-3,500
| Closed | -$440K | – | 138 |
|
|
2021
Q3 | $440K | Buy |
+3,500
| New | +$440K | 0.06% | 65 |
|
|
2021
Q2 | – | Sell |
-8,735
| Closed | -$1.19M | – | 117 |
|
|
2021
Q1 | $1.19M | Buy |
+8,735
| New | +$1.19M | 0.23% | 34 |
|
|
2020
Q3 | – | Sell |
-2,150
| Closed | -$241K | – | 96 |
|
|
2020
Q2 | $241K | Buy |
+2,150
| New | +$241K | 0.05% | 34 |
|
|
2019
Q1 | – | Sell |
-62,266
| Closed | -$4.47M | – | 98 |
|
|
2018
Q4 | $4.47M | Buy |
+62,266
| New | +$4.47M | 0.98% | 4 |
|
|
2017
Q1 | – | Sell |
-11,700
| Closed | -$693K | – | 191 |
|
|
2016
Q4 | $693K | Buy |
+11,700
| New | +$693K | 0.04% | 71 |
|
|
2014
Q2 | – | Sell |
-131,235
| Closed | -$6.23M | – | 146 |
|
|
2014
Q1 | $6.23M | Buy |
+131,235
| New | +$6.23M | 0.35% | 8 |
|